COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 25 | -19.4% | 0.00% | – |
| Q3 2022 | $3,000 | -98.5% | 31 | -99.8% | 0.00% | -100.0% |
| Q3 2018 | $195,000 | -25.0% | 13,250 | +21.6% | 0.01% | -27.3% |
| Q2 2018 | $260,000 | +89.8% | 10,900 | +47.3% | 0.01% | +83.3% |
| Q1 2018 | $137,000 | 0.0% | 7,400 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $137,000 | +75.6% | 7,400 | 0.0% | 0.01% | +100.0% |
| Q3 2017 | $78,000 | -2.5% | 7,400 | +15.6% | 0.00% | 0.0% |
| Q2 2017 | $80,000 | +25.0% | 6,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $64,000 | -34.0% | 6,400 | +3.2% | 0.00% | -40.0% |
| Q4 2016 | $97,000 | -16.4% | 6,200 | +3.3% | 0.01% | -16.7% |
| Q3 2016 | $116,000 | +75.8% | 6,000 | +7.1% | 0.01% | +50.0% |
| Q2 2016 | $66,000 | – | 5,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |